ArticleAsia-Pacific journal of oncology nursing2026
Development and psychometric testing of the urostomy peristomal skin symptom questionnaire.
Article in Asia-Pacific journal of oncology nursing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: While current assessment tools for peristomal skin complications (PSCs) provide valuable assessment of clinician-observed signs, a comprehensive understanding of the condition requires the integration of the patient's perspective on their symptom experience. This study aimed to develop and validate the Urostomy Peristomal Skin Symptom Questionnaire (UPSS), a novel patient-reported outcome measure designed to comprehensively assess the symptom experience in urostomy patients. Methods: Following established methodological standards, this study was conducted in three sequential phases involving 508 urostomy patients: scale development, incorporating a literature review, qualitative interviews, Delphi expert consultation, and cognitive interviewing; initial testing, featuring item analysis and exploratory factor analysis (EFA); and psychometric validation via a cross-sectional survey to assess reliability and validity. Results: The final 29-item UPSS encompasses seven dimensions within two subscales (Symptom Discomfort and Symptom Impact). The scale exhibits strong content validity (S-CVI/Ave = 0.980), good construct validity supported by both exploratory and confirmatory factor analysis, and high reliability (Cronbach's α = 0.881; test-retest intraclass correlation coefficients [ICC] = 0.892). Conclusions: The UPSS is a rigorously developed and psychometrically robust instrument that provides the first comprehensive, patient-centered assessment of peristomal skin symptom burden in urostomy care. By enabling the identification of the "invisible" population burdened by specific symptom clusters and their impacts, the UPSS holds substantial promise for refining clinical practice, guiding personalized interventions, and advancing patient-centered outcomes research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.